Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit

Waters Corporation (NYSE:WAT) shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV Self-Collection Kit, a significant step in expanding access to cervical cancer screening.